GE Healthcare and Sealed Air enter an exclusive agreement to deliver film for Single-Use bioprocess systems
CHALFONT ST. GILES, UK and CHARLOTTE, NC – August 17, 2016 – GE Healthcare’s Life Sciences business, a global provider of technologies and expertise to the biopharmaceutical and life sciences industries and Sealed Air Corporation, a global manufacturer of primary films for pharmaceutical solutions, today announced the expansion of a strategic alliance designed to further the development and innovation in the biopharmaceuticals industry.
The agreement marks the next stage of a long-term collaboration between GE and Sealed Air, following a successful research and development agreement which created a new film suitable for use across GE’s full Single-Use portfolio, exceptional superior cell growth, application robustness, and enhancing security of supply.
Morgan Norris, GM of Upstream Products at GE Healthcare’s Life Sciences business commented, “GE and Sealed Air share a vision of the importance of robust high quality films in the efficient manufacturing of life saving medicines such as monoclonal antibodies, vaccines and next generation biotherapeutics. Through this agreement we are confident that we will deliver the next level of purposefully constructed and manufactured films for bioprocessing applications, enabling improved performance, supply chain control, and material/supplier transparency that the market demands of Single-Use suppliers.”
Gareth Crain, Vice President and General Manager of Sealed Air’s Medical Applications division added, “The combination of GE’s industry knowledge and breadth of product portfolio, with our experience, established proven compliance and quality systems in the pharmaceutical market space will enable us to deliver film solutions uniquely suited to the needs of Single-Use technology. This agreement provides a great platform for us to leverage our expertise in polymers, pharmaceutical regulatory and in-market requirements. We have been present in the parenteral market for many years where our Nexcel® M312 film is considered to be best in class for IV solutions.”
About Sealed Air
Sealed Air Corporation creates a world that feels, tastes and works better. In 2015, the Company generated revenue of approximately $7.0 billion by helping our customers achieve their sustainability goals in the face of today’s biggest social and environmental challenges. Our portfolio of widely recognized brands, including Cryovac® brand food packaging solutions, Bubble Wrap® brand cushioning and Diversey® cleaning and hygiene solutions, enables a safer and less wasteful food supply chain, protects valuable goods shipped around the world, and improves health through clean environments. Sealed Air has approximately 23,000 employees who serve customers in 169 countries. To learn more, visit www.sealedair.com
About Sealed Air Medical Applications
Sealed Air’s Medical Applications business is a leading global manufacturer of materials designed for the healthcare industry, including films for pharmaceutical solutions and barrier films for stoma and ostomy pouches marketed and sold under the NEXCEL® brand.
About GE Healthcare
GE Healthcare provides transformational medical technologies and services to meet the demand for increased access, enhanced quality and more affordable healthcare around the world. GE (NYSE: GE) works on things that matter - great people and technologies taking on tough challenges. From medical imaging, software & IT, patient monitoring and diagnostics to drug discovery, biopharmaceutical manufacturing technologies and performance improvement solutions, GE Healthcare helps medical professionals deliver great healthcare to their patients. For more information about GE Healthcare, visit our website at www.gehealthcare.com.
About GE Healthcare Life Sciences
GE Healthcare's $4B Life Sciences business is on a mission to accelerate an age of molecular and
precision medicine by providing expertise, tools and solutions for a wide range of applications,
including basic research of cells and proteins, drug discovery, cell therapy and regenerative
medicine, as well as tools and technology to support large-scale manufacturing of
biopharmaceuticals, vaccines and biologics such as insulin. It also supplies leading contrast, PET and
nuclear medicine agents for diagnostic imaging to help doctors make more informed diagnoses for
better patient outcomes. The company's mission is to help enable a new era of molecular and
precision medicine by providing customers with the tools, insight and knowledge to guide them ever
more quickly from better biological understanding to better clinical therapies.